Reshape Lifesciences Inc. (HIND) SEC Filings — 2024
19 SEC filings for Reshape Lifesciences Inc. (HIND) in 2024.
Filings
- ReShape Lifesciences Files 8-K with Material Agreement — 8-K · Dec 27, 2024
- ReShape Lifesciences Files S-1 — S-1 · Dec 20, 2024
- ReShape Lifesciences Files 8-K — 8-K · Dec 11, 2024
- ReShape Lifesciences Faces Nasdaq Delisting — 8-K · Dec 2, 2024
- ReShape Lifesciences Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- ReShape Lifesciences Inc. Reports Material Definitive Agreement and Equity Sales — 8-K · Oct 17, 2024
- Reshape Lifesciences Inc. SC 13G/A Filing — SC 13G/A · Sep 26, 2024
- ReShape Lifesciences to be Acquired by HealthBeacon Affiliate — 8-K · Sep 24, 2024
- ReShape Lifesciences Q2 2024: Revenue Dip, Asset/Liability Balance — 10-Q · Aug 14, 2024
- ReShape Lifesciences Sells Lap-Band Assets, Appoints New Directors — 8-K · Jul 9, 2024
- ReShape Lifesciences Files 8-K on Financials — 8-K · May 20, 2024
- ReShape Lifesciences Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- ReShape Lifesciences Appoints New Auditor Amidst Accounting Disagreements — 8-K · Apr 10, 2024
- ReShape Lifesciences Files 8-K for Operations Update — 8-K · Apr 4, 2024
- ReShape Lifesciences Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
- ReShape Lifesciences Files 8-K on Shareholder Vote Submission — 8-K · Feb 26, 2024
- ReShape Lifesciences Inc. Announces 2024 Annual Stockholder Meeting — DEF 14A · Jan 24, 2024
- ReShape Lifesciences Faces Delisting Risk, Amends Bylaws — 8-K · Jan 18, 2024
- Yair Schneid Reports 2.46M Share Stake in ReShape Lifesciences — SC 13G · Jan 17, 2024